Industry | 卫生和社会工作业 | ||||||||||||||||||||||||
Company Introduction | 广东星河生物科技股份有限公司是一家从事鲜品食用菌的研发、生产和销售的公司.公司主要产品包括金针菇、真姬菇和白玉菇等鲜品食用菌.至2013年12月31日,公司申请国 家专利30项,其中已获授权23项,取得科技成果10项。2005年星河“出口型无公害食用菌(纯白金针菇)选育及仿生高效栽培高技术产业化示范工程”被国家发改委列入国家高 技术产业发展项目计划。2007年公司与广东省微生物研究所等单位联合实施的“食用菌优质高效大规模生产关键技术研究”获国家科学进步奖二等奖。2008年12月星河被广东省 科学技术厅等四部门联合认定为国家高新技术企业,并于2011年12月通过了国家高新技术企业的复审。公司先后通过ISO9001:2008国际质量管理体系认证、中国农业良好 规范GAP一级认证(由中国检验认证集团质量认证有限公司认证,相当于欧美农业标准操作规范)、绿色食品认证和无公害农产品产地认定(由广东省农业厅认定)。 | ||||||||||||||||||||||||
Main Business | 大型放射性医疗设备的研制、生产和销售以及提供医疗服务 | ||||||||||||||||||||||||
Legal Representative | 彭文 | ||||||||||||||||||||||||
Top Executives |
|
||||||||||||||||||||||||
Top 5 Shareholder |
|
||||||||||||||||||||||||
Company Secretary | 刘泽霖 | ||||||||||||||||||||||||
Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
Auditors | 和信会计师事务所(特殊普通合伙) | ||||||||||||||||||||||||
Tel No | 0532-55776787 | ||||||||||||||||||||||||
Fax No | 0532-55776787 | ||||||||||||||||||||||||
Website | www.inkonlife.com | ||||||||||||||||||||||||
inkonlife@inkonlife.com | |||||||||||||||||||||||||
Company Address |
|
||||||||||||||||||||||||
Listing Date | 09/12/2010 | ||||||||||||||||||||||||
Shares Capital |
|
||||||||||||||||||||||||
EPS(RMB)* | ¥ 0.160 | ||||||||||||||||||||||||
DPS(RMB)* | -- | ||||||||||||||||||||||||
NBV Per Share(RMB)* | ¥ 2.152 | ||||||||||||||||||||||||
Market Capitalization(RMB) | 6.036B |
Only Chinese content is avaliable | |
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
* | Unadjusted Data |
Information provided by: etnet | ||
Terms and Conditions |
Risk Disclosure: |
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
Disclaimer: |
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |